Nyheter & Information

Läs de senaste produktnyheterna och erbjudandena här

• Vi erbjuder nyproducerade och certifierade strålkällor i december

  2022-09-06

  Planera för kalibrering av dina detektorer.

  

• 8th Molecular Blood Group Forum Frankfurt

  2022-08-18

  November 21st/22nd 2022.

  

• Biosearch Technologies brand update

  2022-07-15

  Effective April 2022, the Lucigen brand will start its final phases of transitioning to Biosearch Technologies, LGC’s comprehensive genomics portfolio. They are making this change because Biosearch Technologies unifies all legacy brands under one collective offer. This allows them to provide consistency across all of their products and services so they can deliver optimal support across our customers’ entire genomics workflow and at every stage of their product development pipeline.

  

• Total automation in clinical bacteriology: technology at the service of the patient

  2022-07-11

  A technology to improve patient care.

• DaraEx - anti-CD38 antibody neutralizing agent

  2022-06-21

  Antibody based drugs can disturb serological blood group testing since the examined antigens can be masked by the therapeutic antibodies. An anti-CD38 antibody for treatment of multiple myeloma shows a strong interference in the indirect antiglobulin test (IAT) where most of the reactions turn to unspecifically (wrong) positive. The time consuming standard technique using Dithiothreitol (DTT) counteracts the interference but has major drawbacks like destruction of Kel antigens or hemolysis. The imusyn DaraEx compound inhibits the agglutination effect of anti-CD38 in IAT without side effects.

  

• Ny VD på Nordic Biolabs per den 1 juni, 2022

  2022-06-02

• Nyheter inom decomission system

  2021-06-22

  Här presenteras information om nya samarbetspartners och lösningar som vi hoppas ska kunna lanseras under 2022.